Cybin (HELP) Retained Earnings (2021 - 2026)
Cybin's (HELP) quarterly Retained Earnings came in at $630000.0 in Q1 2026, up 100.27% YoY from $314581.0 in Q1 2025, and up 100.21% on a QoQ basis from -$299.9 million in Q3 2025.
Cybin (HELP) Retained Earnings (2021 - 2026) Analysis & Trends
Cybin (HELP) has 6 years of Retained Earnings data on file, last reported at $630000.0 in Q1 2026.
- Quarterly Retained Earnings rose 100.27% year-over-year to $630000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $630000.0 (up 100.27% YoY) and the FY2026 annual result came in at $630000.0, up 100.25% from the prior year.
- Retained Earnings improved to $630000.0 in Q1 2026, from -$299.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $630000.0 in Q1 2026 to a low of -$299.9 million in Q3 2025.
- A 5-year average of -$158.7 million and a median of -$159.2 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 82.67% — and 2026, when it jumped 100.27%.
- Tracing HELP's Retained Earnings over 5 years: stood at -$99.0 million in 2022, then slumped by 51.96% to -$150.5 million in 2023, then plunged by 46.88% to -$221.0 million in 2024, then plunged by 35.66% to -$299.9 million in 2025, then soared by 100.21% to $630000.0 in 2026.
- The last three Retained Earnings figures came in at $630000.0 (Q1 2026), -$299.9 million (Q3 2025), and -$266.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | 630,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630,000.00 |
| Sep 30, 2025 | -299.87 Mn |
| Jun 30, 2025 | -266.15 Mn |
| Mar 31, 2025 | -236.51 Mn |
| Dec 31, 2024 | -221.05 Mn |
| Sep 30, 2024 | -218.63 Mn |
| Jun 30, 2024 | -176.25 Mn |
| Mar 31, 2024 | -167.89 Mn |
| Dec 31, 2023 | -150.50 Mn |
| Sep 30, 2023 | -130.21 Mn |
| Jun 30, 2023 | -121.10 Mn |
| Feb 28, 2023 | -40.52 Mn |
| Dec 31, 2022 | -99.04 Mn |
| Sep 30, 2022 | -94.84 Mn |
| Dec 31, 2021 | -65.50 Mn |
| Sep 30, 2021 | -51.92 Mn |
| Jun 30, 2021 | -38.84 Mn |
| Mar 31, 2021 | 18,962.38 |